An Exclusive Healthcare Business Research and Consulting Company

Spearhead Acuity-Business Research & Consulting (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Services provided by SA-BRC

Syndicate Reports
A repository of market research studies conducted for instant access by our clients at a reasonable price. These reports comprise market data by valve/volume, sub-segments, applications, technologies, geographies, competitive landscape, etc.

Custom Reports (Client specific research)
Either an existing syndicate report is customized to suit the clients’ needs or a completely fresh and customized research is conducted as per the defined requirements from clients. We constantly engage and update our clients through provisional research deliverables to ensure right assessment and research target. We follow a robust research methodology to achieve high quality results which is an amalgamation of secondary and primary sources.

Competitive Intelligence
Major healthcare industry players (more than 50% of the top pharma and medical device manufacturers) are still hesitant in engaging with patients and other stakeholders in the value chain through social media channels. The returns on expenses meted out for social media tracking is difficult to directly equate with sales but definitely helps enhancing it in the long run.

Pharmaceutical Drug Analogue Based Forecasting Tool
The Pukka tool provides access to qualitative and quantitative (U.S. sales) data of over 100 brands for United States market with more brands being added every year. Comparison models frequently present inaccurate predictions if the brands being considered have multiple indications or if brands being considered are only top selling prescriptions, however Pukka considers only those drugs that are FDA approved for single indication only and comprises of both top selling brands as well as those performing below par thus presenting an extremely realistic view of the comparison result.

Drug Analogue Screening & Forecasting Tool@ http://www.sa-brc.com/filters_demo.php

Pukka currently offers analog forecasting for major disease categories such as oncology, metabolic disorder, cardiovascular, central nervous system, skin disease, respiratory, pain management, hematology, urology, autoimmune and auto inflammatory diseases. The database also presents market revenue for United States from approval to 2015 and a forecast of sales to 2022 for all 100 brands! It provides qualitative information on over 36 parameters such as adherence, persistence, molecule, order of entry, efficacy rate, disease condition, clinical manifestation, treatment type, formulation type, orphan designation, pharmacologic class, indication, disease category, route of administration, indication specificity, days of therapy, dosing frequency, cost per day, reimbursement tier, current ownership and others. The market forecast has been estimated using the most accurate prediction systems using base values gathered from annual reports and patient based forecasting techniques.

Consulting Projects & Survey Data Analysis
Similar to our customized research services, we also provide full-fledged consulting services in the domain of healthcare and life sciences. Clients remain updated through provisional research deliverables to ensure research target points are achieved. A pilot survey with 5%-10% sample respondents is conducted to ensure that the questionnaire is robust enough to capture answers to all the questions.

Most of the consulting projects are focused on the following research areas:
• Message Testing Studies with Prescribing Physicians
• Perceptual Mapping
• Unmet Need Analysis
• Cost - Benefit Analysis
• Pricing & Reimbursement Studies
• Disease Assessment
• Market Entry Strategy Studies

KOL Mapping
Though there has been addition to the list of parameters that guides doctor’s prescription pattern, influence of KOLs remains the most impactful of all these factors: years of practice, CMEs, journal meta-analysis articles, patient involvement, managed care activities. SA-BRC team helps our client with an excel spreadsheet deliverable that captures KOLs by geographies (regions & countries) alongside other parameters listed below:

KOL’s: Rank (based on the overall score)
1. Full Name
2. Total Citation Score
3. Total Journal Impact Factor Score
4. Count and details of the research publications till date
5. Count and details of Clinical Trials (in which the KOL is/was involved)
6. Additional responsibilities and involvement such as:
7. Editorial board head/member
8. Influence on Medicare/Medicaid reimbursement policies/reforms
9. Head/member of Patient Advocacy Groups
10. Receiver of Awards/Grants/Honors
11. Organization Name
12. Geographic Location
13. Contact Details:
14. E-mail ID (Official/Personal)
15. Contact Number (Office/Residence/Desk/Mobile)
16. Other parameters as per specific client requirement

For Research Reports@ http://www.sa-brc.com/

Social Media Analytics
Major healthcare industry players (more than 50% of the top pharma and medical device manufacturers) are still hesitant in engaging with patients and other stakeholders in the value chain through social media channels. The returns on expenses meted out for social media tracking is difficult to directly equate with sales but definitely helps enhancing it in the long run.

Health Economics & Outcome Research Assessment
HEOR plays a critical role in deciding the fate of drugs and medical device technologies across multiple parameters such as - price, efficiency, adverse reactions, availability, disease burden, QUALY measurements, etc. HEOR studies are considered basis for evaluating a drug/device’s impact on patients quality of life.

John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
India

For Further Info Contact Us
Email: support@sa-brc.com
Website: www.sa-brc.com
Phone: +91-02041210872

This release was published on openPR.